Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1167403

	registered interest
	date	30/10/2019
	answering body	Treasury
	answering dept id	14
	answering dept short name	Treasury
	answering dept sort name	Treasury
	hansard heading	Cash Dispensing: Fees and Charges
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Chancellor of the Exchequer, what assessment he has made of the effect of interchange fee reductions on the number of free-to-use ATMs.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	7626
	answer	answer is ministerial correction date of answer 04/11/2019 answer text <p>The Government has not carried out a formal assessment of the effect of interchange fee reductions on the number of free-to-use ATMs.</p><p> </p><p>Although the management and deployment of ATMs is a commercial matter for ATM market participants, the Government recognises that widespread access to cash remains extremely important to the day-to-day lives of many consumers and businesses in the UK.</p><p> </p><p>The number of free-to-use ATMs increased for over a decade up to 2017, with the majority of ATMs clustered in areas of high demand and footfall. LINK, the scheme that runs the UK’s ATM network, saw this situation as unsustainable. Therefore, in January 2018, LINK announced reductions to the interchange fee, while taking steps to preserve the broad geographic spread of free-to-use ATMs. This included protections for remote free-to-use ATMs, one kilometre or further from the next nearest free-to-use ATM or Post Office.</p><p> </p><p>In July 2018, LINK responded to lower transaction volumes at ATMs by cancelling the third reduction of interchange fees due in January 2020 and putting on hold the 4th reduction that was due in January 2021.</p><p> </p><p>More recently, LINK committed to protecting free access to cash on high streets – where there are five or more qualifying retailers – and announced £1 million to fund requests for new ATMs from local areas with poor access to cash. Furthermore, UK Finance – the trade association for the UK banking and financial services sector – has launched a Community Access to Cash Initiative, offering grants to local communities to improve cash access.</p><p> </p><p>As of June 2019, there were 48,500 free-to-use ATMs in the UK, which represented 78% of the total number of ATMs. This remains 21% higher than a decade ago.</p> answering member constituency Salisbury answering member printed John Glen grouped question UIN 7628 question first answered 04/11/2019 16:02:09 answering member 4051 label Biography information for John Glen
	tabling member	151 label Biography information for Tom Brake

1167492

	registered interest
	date	30/10/2019
	answering body	Treasury
	answering dept id	14
	answering dept short name	Treasury
	answering dept sort name	Treasury
	hansard heading	Cash Dispensing: Fees and Charges
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Chancellor of the Exchequer, what assessment he has made of the effect of interchange fee reductions on the number of free-to-use ATMs.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	7628
	answer	answer is ministerial correction date of answer 04/11/2019 answer text <p>The Government has not carried out a formal assessment of the effect of interchange fee reductions on the number of free-to-use ATMs.</p><p> </p><p>Although the management and deployment of ATMs is a commercial matter for ATM market participants, the Government recognises that widespread access to cash remains extremely important to the day-to-day lives of many consumers and businesses in the UK.</p><p> </p><p>The number of free-to-use ATMs increased for over a decade up to 2017, with the majority of ATMs clustered in areas of high demand and footfall. LINK, the scheme that runs the UK’s ATM network, saw this situation as unsustainable. Therefore, in January 2018, LINK announced reductions to the interchange fee, while taking steps to preserve the broad geographic spread of free-to-use ATMs. This included protections for remote free-to-use ATMs, one kilometre or further from the next nearest free-to-use ATM or Post Office.</p><p> </p><p>In July 2018, LINK responded to lower transaction volumes at ATMs by cancelling the third reduction of interchange fees due in January 2020 and putting on hold the 4th reduction that was due in January 2021.</p><p> </p><p>More recently, LINK committed to protecting free access to cash on high streets – where there are five or more qualifying retailers – and announced £1 million to fund requests for new ATMs from local areas with poor access to cash. Furthermore, UK Finance – the trade association for the UK banking and financial services sector – has launched a Community Access to Cash Initiative, offering grants to local communities to improve cash access.</p><p> </p><p>As of June 2019, there were 48,500 free-to-use ATMs in the UK, which represented 78% of the total number of ATMs. This remains 21% higher than a decade ago.</p> answering member constituency Salisbury answering member printed John Glen grouped question UIN 7626 question first answered 04/11/2019 16:02:09 answering member 4051 label Biography information for John Glen
	tabling member	151 label Biography information for Tom Brake

1167062

	registered interest
	date	29/10/2019
	answering body	Foreign and Commonwealth Office
	answering dept id	16
	answering dept short name	Foreign and Commonwealth Office
	answering dept sort name	Foreign and Commonwealth Office
	hansard heading	Sri Lanka: Power Stations
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Foreign and Commonwealth Affairs, with reference to the Answer of 30 April 2019 to Question 245704 on Sri Lanka: Power Stations, what progress has been made by the Sri Lankan Government on providing compensation to residents; and what assessment he has made of the (a) sufficiency and (b) effect on residents of that compensation.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	7029
	answer	answer is ministerial correction date of answer 05/11/2019 answer text <p>We are aware of the challenges Sri Lanka faces around water management and quality. Staff at the British High Commission in Colombo raise the issue of water quality in northern Sri Lanka regularly, including during a recent visit to Jaffna in August.</p><p>We understand that compensation has been offered to those affected by water pollution caused by the Chunnakam Power plant. We hope that the settlement will be adequate compensation for the victims of contamination, and that measures are taken to ensure clean water.</p><p>A number of public bodies in Sri Lanka including the national water supply and drainage board have conducted tests and further investigations into the contamination are ongoing.</p> answering member constituency South Derbyshire answering member printed Mrs Heather Wheeler grouped question UIN 7030 question first answered 05/11/2019 08:30:34 answering member 4053 label Biography information for Mrs Heather Wheeler
	tabling member	151 label Biography information for Tom Brake

1167063

	registered interest
	date	29/10/2019
	answering body	Foreign and Commonwealth Office
	answering dept id	16
	answering dept short name	Foreign and Commonwealth Office
	answering dept sort name	Foreign and Commonwealth Office
	hansard heading	Sri Lanka: Power Stations
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Foreign and Commonwealth Affairs, with reference to the water pollution in Northern Sri Lanka caused by the Chunnakam power plant, what steps his Department has taken to help secure an independent international investigation into the (a) effects and (b) impact of that water pollution on the community resident in that area.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	7030
	answer	answer is ministerial correction date of answer 05/11/2019 answer text <p>We are aware of the challenges Sri Lanka faces around water management and quality. Staff at the British High Commission in Colombo raise the issue of water quality in northern Sri Lanka regularly, including during a recent visit to Jaffna in August.</p><p>We understand that compensation has been offered to those affected by water pollution caused by the Chunnakam Power plant. We hope that the settlement will be adequate compensation for the victims of contamination, and that measures are taken to ensure clean water.</p><p>A number of public bodies in Sri Lanka including the national water supply and drainage board have conducted tests and further investigations into the contamination are ongoing.</p> answering member constituency South Derbyshire answering member printed Mrs Heather Wheeler grouped question UIN 7029 question first answered 05/11/2019 08:30:34 answering member 4053 label Biography information for Mrs Heather Wheeler
	tabling member	151 label Biography information for Tom Brake

1149209

	registered interest
	date	15/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radioisotopes: Imports
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the August 2019 British Nuclear Medicine Society's open letter to the Prime Minister on radioisotope delivery, what assessment his Department has made of the effect on the costs of radioisotope delivery of the UK leaving the EU without a deal.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	400
	answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including medical radioisotopes, once we have left the EU.</p><p>The Department’s plans include implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a>.</p><p>The supply of medical radioisotopes is being handled by dedicated officials, in collaboration with Devolved Administrations, the Crown Dependencies and Overseas Territories, as these products have particularly short shelf lives and therefore cannot be stockpiled, as well as having complex transport requirements given the radioactivity involved.</p><p> </p><p>The Department, together with other Government Departments and representatives from industry (suppliers and couriers), has also successfully completed an operational testing exercise to help to ensure the uninterrupted flow of medical radioisotopes if the UK leaves the EU without a deal. This has allowed us to test the resilience of the supply chain arrangements for medical radioisotopes.</p><p> </p><p>Prices of medicines often vary due to a wide variety of factors under normal conditions and there is no evidence that the cost of medicines to the NHS are outside of expected ranges. We will continue to monitor this<em>. </em>The UK Government is working closely with the Devolved Administrations, the NHS and suppliers of medical radioisotopes to monitor the costs of radiopharmaceuticals to the NHS in 2019-20.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 402 403 405 question first answered 21/10/2019 13:06:43 answering member 4362 label Biography information for Edward Argar
	tabling member	151 label Biography information for Tom Brake

1149365

	registered interest
	date	15/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radioisotopes: Imports
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the joint letter of 1 August 2019 from the British Nuclear Medicine Society and the Royal College of Radiologists to the Prime Minister entitled continued supply of medical radioisotopes in the event of a no-deal Brexit, if the NHS will allocate additional funding to NHS trusts to cover increased costs incurred for the supply of medical isotopes in the event that the UK leaves the EU without a deal.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	403
	answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including medical radioisotopes, once we have left the EU.</p><p>The Department’s plans include implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a>.</p><p>The supply of medical radioisotopes is being handled by dedicated officials, in collaboration with Devolved Administrations, the Crown Dependencies and Overseas Territories, as these products have particularly short shelf lives and therefore cannot be stockpiled, as well as having complex transport requirements given the radioactivity involved.</p><p> </p><p>The Department, together with other Government Departments and representatives from industry (suppliers and couriers), has also successfully completed an operational testing exercise to help to ensure the uninterrupted flow of medical radioisotopes if the UK leaves the EU without a deal. This has allowed us to test the resilience of the supply chain arrangements for medical radioisotopes.</p><p> </p><p>Prices of medicines often vary due to a wide variety of factors under normal conditions and there is no evidence that the cost of medicines to the NHS are outside of expected ranges. We will continue to monitor this<em>. </em>The UK Government is working closely with the Devolved Administrations, the NHS and suppliers of medical radioisotopes to monitor the costs of radiopharmaceuticals to the NHS in 2019-20.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 400 402 405 question first answered 21/10/2019 13:06:43 answering member 4362 label Biography information for Edward Argar
	tabling member	151 label Biography information for Tom Brake

1149367

	registered interest
	date	15/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radioisotopes: Imports
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the joint letter of 1 August 2019 from the British Nuclear Medicine Society and the Royal College of Radiologists to the Prime Minister entitled continued supply of medical radioisotopes in the event of a no-deal Brexit, if his Department will respond to the concerns raised in that letter about the timely delivery of medical radioisotopes to the North of England, the South West of England, Wales, Scotland and Northern Ireland.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	405
	answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including medical radioisotopes, once we have left the EU.</p><p>The Department’s plans include implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a>.</p><p>The supply of medical radioisotopes is being handled by dedicated officials, in collaboration with Devolved Administrations, the Crown Dependencies and Overseas Territories, as these products have particularly short shelf lives and therefore cannot be stockpiled, as well as having complex transport requirements given the radioactivity involved.</p><p> </p><p>The Department, together with other Government Departments and representatives from industry (suppliers and couriers), has also successfully completed an operational testing exercise to help to ensure the uninterrupted flow of medical radioisotopes if the UK leaves the EU without a deal. This has allowed us to test the resilience of the supply chain arrangements for medical radioisotopes.</p><p> </p><p>Prices of medicines often vary due to a wide variety of factors under normal conditions and there is no evidence that the cost of medicines to the NHS are outside of expected ranges. We will continue to monitor this<em>. </em>The UK Government is working closely with the Devolved Administrations, the NHS and suppliers of medical radioisotopes to monitor the costs of radiopharmaceuticals to the NHS in 2019-20.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 400 402 403 question first answered 21/10/2019 13:06:43 answering member 4362 label Biography information for Edward Argar
	tabling member	151 label Biography information for Tom Brake

1149361

	registered interest
	date	15/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radioisotopes: Imports
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his Department's policies of the matters raised in the joint letter of 1 August 2019 from the British Nuclear Medicine Society and the Royal College of Radiologists to the Prime Minister entitled continued supply of medical radioisotopes in the event of a no-deal Brexit.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	402
	answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including medical radioisotopes, once we have left the EU.</p><p>The Department’s plans include implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a>.</p><p>The supply of medical radioisotopes is being handled by dedicated officials, in collaboration with Devolved Administrations, the Crown Dependencies and Overseas Territories, as these products have particularly short shelf lives and therefore cannot be stockpiled, as well as having complex transport requirements given the radioactivity involved.</p><p> </p><p>The Department, together with other Government Departments and representatives from industry (suppliers and couriers), has also successfully completed an operational testing exercise to help to ensure the uninterrupted flow of medical radioisotopes if the UK leaves the EU without a deal. This has allowed us to test the resilience of the supply chain arrangements for medical radioisotopes.</p><p> </p><p>Prices of medicines often vary due to a wide variety of factors under normal conditions and there is no evidence that the cost of medicines to the NHS are outside of expected ranges. We will continue to monitor this<em>. </em>The UK Government is working closely with the Devolved Administrations, the NHS and suppliers of medical radioisotopes to monitor the costs of radiopharmaceuticals to the NHS in 2019-20.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 400 403 405 question first answered 21/10/2019 13:06:43 answering member 4362 label Biography information for Edward Argar
	tabling member	151 label Biography information for Tom Brake

1148275

	registered interest
	date	03/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of reported customs delays at East Midlands airport on the delivery of category 1 medicines.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	294083
	answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products once we have left the EU.</p><p> </p><p>The department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>For any products that require air freight, such as some medical radioisotopes, the Department is continuing to work with all suppliers to ensure this is in place ahead of 31 October. The Department can confirm that all relevant suppliers now have plans in place or are already airfreighting into the United Kingdom.</p><p> </p><p>The Department is also undertaking joint operational testing, with key suppliers and other Government Departments (Border Delivery Group, HM Revenue and Customs, Border Force) at East Midlands airport to ensure the uninterrupted flow of goods. This testing includes medical radioisotopes.</p><p> </p><p>The Department is in active communication with the British Nuclear Medicine Society as well as with the Royal College of Radiologists and the UK Radiopharmacy Group.</p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 294085 question first answered 08/10/2019 12:53:16 answering member 4362 label Biography information for Edward Argar
	tabling member	151 label Biography information for Tom Brake

1148277

	registered interest
	date	03/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radioisotopes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with representatives from the British Nuclear Medicine Society on the delivery of medical radioisotopes.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	294085
	answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products once we have left the EU.</p><p> </p><p>The department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>For any products that require air freight, such as some medical radioisotopes, the Department is continuing to work with all suppliers to ensure this is in place ahead of 31 October. The Department can confirm that all relevant suppliers now have plans in place or are already airfreighting into the United Kingdom.</p><p> </p><p>The Department is also undertaking joint operational testing, with key suppliers and other Government Departments (Border Delivery Group, HM Revenue and Customs, Border Force) at East Midlands airport to ensure the uninterrupted flow of goods. This testing includes medical radioisotopes.</p><p> </p><p>The Department is in active communication with the British Nuclear Medicine Society as well as with the Royal College of Radiologists and the UK Radiopharmacy Group.</p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 294083 question first answered 08/10/2019 12:53:16 answering member 4362 label Biography information for Edward Argar
	tabling member	151 label Biography information for Tom Brake